Funding for this research was provided by:
National Health and Medical Research Council (403000 & 436797)
Text and Data Mining valid from 2018-12-13
Received: 17 May 2018
Accepted: 22 October 2018
First Online: 13 December 2018
Duality of interest
: MLC, RB, CM, WW and VKS have no conflicts of interest to declare. TP is on the Genzyme advisory board on Fabry disease, and has received payment for lectures including service on speakers’ bureaus for Bayer, Boehringer Ingelheim, Pfizer and Genzyme.